A new endogenous anxiolytic agent: L-pyroglutamic acid

Fundam Clin Pharmacol. 1988;2(2):77-82. doi: 10.1111/j.1472-8206.1988.tb00623.x.

Abstract

By use of a simple anticonflict procedure (Vogel test), it was demonstrated that L-pyroglutamic acid (L-pyrrolidone carboxylic acid [L-PCA]), an amino acid naturally occurring in mammalian tissues and fluids, possesses anxiolytic activity. This tissues and fluids, possesses anxiolytic activity. This effect was stereospecific (D-PCA was inactive) and, in the rat, it was not associated with a decrease in motor activity. Ro 15-1788, a benzodiazepine antagonist, did not modify L-PCA actions. Furthermore, anxiolytic doses of the amino acid did not change the content of 5-hydroxytryptamine (5-HT) or of 5-hydroxyindoleacetic acid (5-HIAA) in the rat cortex and hippocampus. These results suggest that the mechanism of the anxiolytic activity of L-PCA is different from that of the benzodiazepines and of 5-HT1a agonists.

MeSH terms

  • Animals
  • Anti-Anxiety Agents / pharmacology*
  • Cerebral Cortex / drug effects
  • Cerebral Cortex / metabolism
  • Flumazenil / pharmacology
  • Hippocampus / drug effects
  • Hippocampus / metabolism
  • Hydroxyindoleacetic Acid / metabolism
  • Male
  • Motor Activity / drug effects*
  • Pyrrolidonecarboxylic Acid / pharmacology
  • Rats
  • Rats, Inbred Strains
  • Serotonin / metabolism

Substances

  • Anti-Anxiety Agents
  • Serotonin
  • Flumazenil
  • Hydroxyindoleacetic Acid
  • Pyrrolidonecarboxylic Acid